Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Jul;34(7):977–983. doi: 10.1136/gut.34.7.977

Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis.

S Bloom 1, A Heryet 1, K Fleming 1, R W Chapman 1
PMCID: PMC1374238  PMID: 8344587

Abstract

The distribution of carbohydrate antigens of the ABO, Lewis, and Kell systems was examined in biliary and colonic epithelial of 11 patients with primary sclerosing cholangitis (PSC) using a panel of 11 monoclonal antibodies. Controls consisted of 27 liver biopsy specimens (11 normal, six alcoholic liver disease, five extrahepatic obstruction, and five primary biliary cirrhosis) and 24 colonic biopsy specimens (six normal, four Crohn's disease, and 14 ulcerative colitis). There was inappropriate staining with anti-A (four of six, 66%) and anti-B (nine of 11, 81%) in biliary epithelium of PSC patients compared with normal and disease controls. Expression of Lewis antigens was increased in patients with cholestatic liver disease. Ninety one per cent of PSC patients showed a similar pattern of inappropriate staining by anti-A and anti-B antibodies in colonic epithelium compared with 33% of normal and 42% of inflammatory bowel disease controls. There is inappropriate expression of A and B carbohydrate antigens in biliary and colonic epithelium in PSC. Whether these oncofetal antigens are implicated in the pathogenesis of this condition is discussed.

Full text

PDF
977

Images in this article

980Figure 1
on p.980
981Figure 2
on p.981

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodenheimer H. C., Jr, LaRusso N. F., Thayer W. R., Jr, Charland C., Staples P. J., Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology. 1983 Mar-Apr;3(2):150–154. doi: 10.1002/hep.1840030203. [DOI] [PubMed] [Google Scholar]
  2. Boland C. R., Lance P., Levin B., Riddell R. H., Kim Y. S. Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: early results of a prospective study. Gut. 1984 Dec;25(12):1364–1371. doi: 10.1136/gut.25.12.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brinch L., Teisberg P., Schrumpf E., Akesson I. The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scand J Gastroenterol. 1982 Jun;17(4):523–527. doi: 10.3109/00365528209182243. [DOI] [PubMed] [Google Scholar]
  4. Chapman R. W., Arborgh B. A., Rhodes J. M., Summerfield J. A., Dick R., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct;21(10):870–877. doi: 10.1136/gut.21.10.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chapman R. W., Cottone M., Selby W. S., Shepherd H. A., Sherlock S., Jewell D. P. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut. 1986 Jan;27(1):86–91. doi: 10.1136/gut.27.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chapman R. W., Kelly P. M., Heryet A., Jewell D. P., Fleming K. A. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut. 1988 Apr;29(4):422–427. doi: 10.1136/gut.29.4.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chapman R. W., Varghese Z., Gaul R., Patel G., Kokinon N., Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut. 1983 Jan;24(1):38–41. doi: 10.1136/gut.24.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ernst C., Atkinson B., Wysocka M., Blaszczyk M., Herlyn M., Sears H., Steplewski Z., Koprowski H. Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab Invest. 1984 Apr;50(4):394–400. [PubMed] [Google Scholar]
  9. Fukushima K., Hirota M., Terasaki P. I., Wakisaka A., Togashi H., Chia D., Suyama N., Fukushi Y., Nudelman E., Hakomori S. Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res. 1984 Nov;44(11):5279–5285. [PubMed] [Google Scholar]
  10. Gane P., Mollicone R., Rouger P., Oriol R. Inhibition of haemagglutination with Synsorbs and salivas of anti-A monoclonal antibodies. Rev Fr Transfus Immunohematol. 1987 Dec;30(5):435–442. doi: 10.1016/s0338-4535(87)80102-2. [DOI] [PubMed] [Google Scholar]
  11. Hansen P. G., Jackson G. D. Movement of IgM antibody from blood to bile in rats. Hepatology. 1991 Sep;14(3):518–522. [PubMed] [Google Scholar]
  12. Jinno K., Moriwaki S., Govindarajan S., Okada Y., Tsuji T. Blood group antigens in the intrahepatic biliary tree. II. Type 1 chain N-acetyllactosamine-related carbohydrate antigens in the proliferated bile ductules. J Hepatol. 1989 May;8(3):330–337. doi: 10.1016/0168-8278(89)90031-7. [DOI] [PubMed] [Google Scholar]
  13. LaRusso N. F., Wiesner R. H., Ludwig J., MacCarty R. L. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984 Apr 5;310(14):899–903. doi: 10.1056/NEJM198404053101407. [DOI] [PubMed] [Google Scholar]
  14. Leray G., Deugnier Y., Jouanolle A. M., Lehry D., Bretagne J. F., Campion J. P., Brissot P., Le Treut A. Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma. Hepatology. 1989 Feb;9(2):249–252. doi: 10.1002/hep.1840090214. [DOI] [PubMed] [Google Scholar]
  15. Lindor K. D., Wiesner R. H., Katzmann J. A., LaRusso N. F., Beaver S. J. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci. 1987 Jul;32(7):720–725. doi: 10.1007/BF01296138. [DOI] [PubMed] [Google Scholar]
  16. Marshall J. S., Green A. M., Pensky J., Williams S., Zinn A., Carlson D. M. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Invest. 1974 Sep;54(3):555–562. doi: 10.1172/JCI107792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Minuk G. Y., Angus M., Brickman C. M., Lawley T. J., Frank M. M., Hoofnagle J. H., Jones E. A. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology. 1985 Jan;88(1 Pt 1):166–170. doi: 10.1016/s0016-5085(85)80149-9. [DOI] [PubMed] [Google Scholar]
  18. Mollicone R., Gane P., Rouger P., Oriol R. Inhibition of haemagglutination with Synsorbs and salivas of anti-B and anti-AB monoclonal antibodies. Rev Fr Transfus Immunohematol. 1987 Dec;30(5):579–587. doi: 10.1016/s0338-4535(87)80120-4. [DOI] [PubMed] [Google Scholar]
  19. Okada Y., Arima T., Togawa K., Nagashima H., Jinno K., Moriwaki S., Kunitomo T., Thurin J., Koprowski H. Neoexpression of ABH and Lewis blood group antigens in human hepatocellular carcinomas. J Natl Cancer Inst. 1987 Jan;78(1):19–28. doi: 10.1093/jnci/78.1.19. [DOI] [PubMed] [Google Scholar]
  20. Okada Y., Jinno K., Moriwaki S., Shimoe T., Tsuji T., Murakami M., Thurin J., Koprowski H. Blood group antigens in the intrahepatic biliary tree. I. Distribution in the normal liver. J Hepatol. 1988 Feb;6(1):63–70. doi: 10.1016/s0168-8278(88)80463-x. [DOI] [PubMed] [Google Scholar]
  21. Okada Y., Usumoto R., Muguruma M., Shimoe T., Sunayama T., Yamada G., Yamamoto K., Yamabuki T., Tsuji T. The hepatocellular expression of a carbohydrate antigen 'sialyl Lewis X' in chronic hepatitis. A novel histological marker for active hepatic necroinflammation. J Hepatol. 1990 Jan;10(1):1–7. doi: 10.1016/0168-8278(90)90065-y. [DOI] [PubMed] [Google Scholar]
  22. Oriol R., Le Pendu J., Mollicone R. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang. 1986;51(3):161–171. doi: 10.1111/j.1423-0410.1986.tb01946.x. [DOI] [PubMed] [Google Scholar]
  23. Orntoft T. F., Greenwell P., Clausen H., Watkins W. M. Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation. Gut. 1991 Mar;32(3):287–293. doi: 10.1136/gut.32.3.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Podolsky D. K., Isselbacher K. J. Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis. Gastroenterology. 1984 Nov;87(5):991–998. [PubMed] [Google Scholar]
  25. SZULMAN A. E. THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE. III. THE A, B, AND H ANTIGENS IN EMBRYOS AND FETUSES FROM 18 MM IN LENGTH. J Exp Med. 1964 Apr 1;119:503–516. doi: 10.1084/jem.119.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SZULMAN A. E. The histological distribution of blood group substances A and B in man. J Exp Med. 1960 Jun 1;111:785–800. doi: 10.1084/jem.111.6.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schrumpf E., Fausa O., Førre O., Dobloug J. H., Ritland S., Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol. 1982 Mar;17(2):187–191. doi: 10.3109/00365528209182038. [DOI] [PubMed] [Google Scholar]
  28. Whiteside T. L., Lasky S., Si L., Van Thiel D. H. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology. 1985 May-Jun;5(3):468–474. doi: 10.1002/hep.1840050321. [DOI] [PubMed] [Google Scholar]
  29. Wiesner R. H., LaRusso N. F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology. 1980 Aug;79(2):200–206. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES